Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT02188602 Withdrawn - Acute Kidney Injury Clinical Trials

Effect of Cumulative Chloride Dose on Development of Acute Kidney Injury in Critically Ill Children

Start date: July 2013
Phase:
Study type: Observational

The investigators would like to investigate the effect of chloride dosing on the development of acute kidney injury in critically ill patients. The investigators hypothesis is that administering intravenous fluids with higher chloride content are more likely to lead to acute kidney injury.

NCT ID: NCT02055599 Withdrawn - Chronic Wounds Clinical Trials

WEMR With Clinical Decision Support for All Wounds

Start date: April 2013
Phase:
Study type: Observational

The goal of this project to begin using a wound research database with clinical decision support features at Winthrop University Hospital. A research database is an electronic computer system that is used to collect patient information. Clinical decision support is the ability for a computer system to provide medical assistance to the doctor through alerts and recommendations based on the information entered. The investigators believe that use of a wound clinical decision support tool, much like a drug, will improve healing in patients with chronic wounds (wounds that fail to heal over the course of weeks) and ultimately lower the risk of death and illness caused by these wounds. In order to develop a useful clinical decision support tool, investigators first need to develop a large research database to determine the data points important for wound healing. The investigators will be using the data collected in this study for future research and publication. Data will be reviewed to answer questions important to wound healing and for the purpose of developing the clinical decision support alert system. After providing informed consent, participants will be asked a series of questions related to their past medical history, and relevant wound data will be collected. Study staff will photograph the wound at baseline, and once per week until the wound is completely healed, or for a duration of six months. Participants will be expected to return to Winthrop University Hospital for wound follow-up on a regular basis, or as determined by the Principal Investigator.

NCT ID: NCT02047552 Withdrawn - Anemia Clinical Trials

RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone

Start date: January 2015
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to determine if the combination of goal directed iron supplementation and hepcidin mitigation can safely eliminate both the serum and bone marrow iron debt of anemic, critically ill trauma patients with functional iron deficiency.

NCT ID: NCT02028104 Withdrawn - Clinical trials for Traumatic Brain Injury

Stem Cell Therapy in Traumatic Brain Injury

Start date: January 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with Traumatic Brain Injury

NCT ID: NCT02027246 Withdrawn - Spinal Cord Injury Clinical Trials

Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury

Start date: December 2008
Phase: Phase 1
Study type: Interventional

The aim of this study was to study the effect of stem cell therapy on common symptoms of spinal cord injury patients.

NCT ID: NCT02009124 Withdrawn - Spinal Cord Injury Clinical Trials

Stem Cell Therapy in Spinal Cord Injury

Start date: August 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to study the effect of stem cell therapy on common symptoms in patients with spinal cord injury.

NCT ID: NCT01973504 Withdrawn - Trauma Clinical Trials

Phase 2c Dose Comparison Study of MP4OX in Trauma

Start date: December 2013
Phase: Phase 2
Study type: Interventional

MP4OX is being developed as an ischemic rescue therapy to perfuse and oxygenate tissues at risk during hemorrhagic shock. MP4OX is a pegylated hemoglobin-based colloid designed to improve perfusion and target delivery of oxygen to ischemic tissues. This study will evaluate safety and efficacy of MP4OX treatment, in addition to standard therapy, in trauma patients suffering from lactic acidosis due to severe hemorrhagic shock.

NCT ID: NCT01922960 Withdrawn - Trauma Clinical Trials

Microcirculatory Assessment in Patients With Trauma and Severe Burns

Start date: April 7, 2012
Phase: N/A
Study type: Interventional

Predict the development of multiple organ failure in patients with trauma and severe burns.

NCT ID: NCT01891383 Withdrawn - Dementia Clinical Trials

Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel

Start date: July 2013
Phase:
Study type: Observational

The objective of this study is to measure the frequency and clinical types of mild cognitive impairment (MCI) or dementia that occur among up to 150 military retirees with and without a history of traumatic brain injury (TBI) among residents of the Armed Forces Retirement Home, Washington D.C. and the Veterans Home of California-Yountville. Investigators will compare the characteristics of dementia in those who have had a prior TBI to the characteristics in those without a history of TBI. It is our hypothesis that the dementia or MCI among those with prior TBI has distinct neuropsychological features that distinguishes it from those with dementia or MCI without a history of TBI.

NCT ID: NCT01852773 Withdrawn - Blunt Injury Clinical Trials

Thoracic Endovascular Repair Versus Open Surgery for Blunt Injury

TEVAR
Start date: May 2013
Phase: N/A
Study type: Observational

This study aims to increase understanding of the short-term and long-term outcome of blunt aortic injury (BAI) and to discern if there is an advantage resulting from the type of operative treatment used to manage it, either the classic open surgical repair or a newer technique known as thoracic endovascular repair (TEVAR). Specifically, this study will answer the following questions regarding patients suffering BAI: 1. What clinical variables affect short-term mortality and neurologic outcome? 2. What are the long-term treatment-associated complications of open repair and TEVAR? 3. In patients with a similar injury and physiologic profile, is there a survival advantage resulting from the type of operative treatment?